Janux Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
RA Capital Management and its affiliates have increased their beneficial ownership in Janux Therapeutics, Inc. to 19.9% through recent open market purchases.